Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Azacytidine and Valproic Acid in Patients With Advanced Cancers

This study has been completed.
Celgene Corporation
Information provided by (Responsible Party):
M.D. Anderson Cancer Center Identifier:
First received: July 2, 2007
Last updated: July 31, 2012
Last verified: July 2012
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2009
  Primary Completion Date: October 2009 (Final data collection date for primary outcome measure)